文献速递骨肌儿科影像MRCTPET

高级别四肢骨内骨肉瘤的跳跃转移:更具侵袭性疾病的指标?

Skip metastases in high-grade intramedullary appendicular osteosarcoma: an indicator of more aggressive disease?
PubMed 文献 · Skeletal Radiol · 2021-05-14

该回顾性研究纳入241例经组织学确诊的高级别四肢长骨骨肉瘤患者,通过全骨MRI识别跳跃转移(SM),并比较有无SM患者的肺转移、骨转移及化疗反应。结果显示SM与肺转移(p<0.001)和骨转移(p<0.001)显著相关,但与化疗反应无关(p=0.24),且SM患者生存更差(p<0.001)。结论认为SM提示更具侵袭性的疾病。

要点

  • 全骨MRI应作为高级别四肢骨肉瘤的常规分期检查,以检出跳跃转移。
  • 发现跳跃转移时,应警惕肺转移和骨转移的高风险,并完善相应分期。
  • 跳跃转移与化疗反应无关,但提示预后更差,需在报告中明确提示。

局限性

  • 回顾性研究设计。
  • 单中心研究。
  • 样本量有限(241例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To determine whether skip metastases (SM) in high-grade appendicular osteosarcoma (HG-OS) are an indicator of more aggressive disease.

MATERIALS AND METHOD: Retrospective review of patients with histologically confirmed diagnosis HG-OS of the long bones from 2007 to 2020, who had whole-bone MRI to identify SM. Data collected included patient age/gender, bone involved, the presence of SM, the presence of lung metastases from chest CT, the presence of distant bone metastases from whole-body bone scintigraphy or whole-body MRI, and chemotherapy response from resection specimen histology. The presence of lung or bone metastases and chemotherapy response were compared between patients without and with SM.

RESULTS: The study included 241 patients (146 males; 95 females: mean age 18.2 years; range 4-73 years). Based on whole-bone MRI, 202 (83.8%) patients had no SM and 39 (16.2%) patients had a SM. Of patients without a SM, lung metastases were identified in 44 (22%) and distant bone metastases in 6 (3%) cases, while 80 (43%) had a good chemotherapy response and 105 (57%) had a poor chemotherapy response. Of patients with a SM, lung metastases were identified in 22 (58%) and distant bone metastases in 8 (21%) cases, while 11 (32%) had a good chemotherapy response and 23 (68%) had a poor chemotherapy response. The presence of SM was significantly associated with both lung metastases (p < 0.001) and skeletal metastases (p < 0.001), but not with chemotherapy response (p = 0.24). Patients with SM also had poorer survival (p < 0.001).

CONCLUSIONS: The presence of SM in appendicular HG-OS suggests more aggressive disease.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Saifuddin A, Michelagnoli M, Pressney I, et al. Skip metastases in high-grade intramedullary appendicular osteosarcoma: an indicator of more aggressive disease? Skeletal Radiol. 2021. PMID: 33990864. doi:10.1007/s00256-021-03814-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。